| Autor: |
Luciano, de Souza Viana, Felipe Coelho, de Aguiar Silva, Alexandre, Andrade Dos Anjos Jacome, Danielle, Calheiros Campelo Maia, Marcos, Duarte de Mattos, Alexandre, Arthur Jacinto, Augusto, Elias Mamere, Domingos, Boldrini Junior, Renato, de Castro Capuzzo, Carlos, Roberto Santos, Andre, Lopes Carvalho |
| Rok vydání: |
2014 |
| Předmět: |
|
| Zdroj: |
Headneck. 38 |
| ISSN: |
1097-0347 |
| Popis: |
The purpose of this phase II trial was to evaluate the tolerability, safety, and efficacy of a non-5-fluorouracil (5-FU)-based induction chemotherapy followed by chemoradiotherapy (CRT) for patients with locally advanced head and neck squamous cell carcinoma (HNSCC).Sixty patients with stage III to IV HNSCC were treated with induction paclitaxel and cisplatin (TP; paclitaxel 175 mg/m(2) and cisplatin 80 mg/m(2) , 3 cycles) followed by CRT (cisplatin 100 mg/m(2) ; D1, 22, and 43 of radiotherapy).Fifty-six patients (93.3%) completed 3 cycles of induction TP (no treatment-related deaths), 52 (86.7%) completed definitive CRT per protocol (adverse event [AE] grade ≥2 in 53.3%). The overall response rate after induction TP was 82.5% for patients with resectable disease and 55.5% for unresectable disease (p = .023), and complete response (CR) rate after CRT was 70.0% for patients with resectable disease and 30.0% for unresectable disease (p = .005).Induction TP followed by cisplatin based-CRT was well-tolerated, safe, and had high overall response rate in selected patients with locally advanced HNSCC. © 2015 Wiley Periodicals, Inc. Head Neck 38: E970-E980, 2016. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
Plný text